Editas Medicine Inc (EDIT)
3.38
+0.18
(+5.62%)
USD |
NASDAQ |
Oct 04, 16:00
3.39
+0.01
(+0.30%)
After-Hours: 20:00
Editas Medicine Shareholders Equity (Annual): 349.10M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 349.10M |
December 31, 2022 | 360.68M |
December 31, 2021 | 553.64M |
December 31, 2020 | 393.59M |
December 31, 2019 | 262.44M |
December 31, 2018 | 236.16M |
Date | Value |
---|---|
December 31, 2017 | 208.08M |
December 31, 2016 | 134.61M |
December 31, 2015 | -83.11M |
December 31, 2014 | -15.29M |
December 31, 2013 | -1.763M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
262.44M
Minimum
2019
553.64M
Maximum
2021
383.89M
Average
360.68M
Median
2022
Shareholders Equity (Annual) Benchmarks
EyePoint Pharmaceuticals Inc | 266.32M |
Cassava Sciences Inc | 137.47M |
Regeneron Pharmaceuticals Inc | 25.97B |
Vertex Pharmaceuticals Inc | 17.58B |
Adverum Biotechnologies Inc | 83.47M |